Literature DB >> 15213709

Consumption of Lactobacillus acidophilus and Bifidobacterium longum do not alter urinary equol excretion and plasma reproductive hormones in premenopausal women.

M J L Bonorden1, K A Greany, K E Wangen, W R Phipps, J Feirtag, H Adlercreutz, M S Kurzer.   

Abstract

OBJECTIVE: To confirm the results of an earlier study showing premenopausal equol excretors to have hormone profiles associated with reduced breast cancer risk, and to investigate whether equol excretion status and plasma hormone concentrations can be influenced by consumption of probiotics.
DESIGN: A randomized, single-blinded, placebo-controlled, parallel-arm trial.
SUBJECTS: In all, 34 of the initially enrolled 37 subjects completed all requirements. INTERVENTION: All subjects were followed for two full menstrual cycles and the first seven days of a third cycle. During menstrual cycle 1, plasma concentrations of estradiol (E(2)), estrone (E(1)), estrone-sulfate (E(1)-S), testosterone (T), androstenedione (A), dehydroepiandrosterone-sulfate (DHEA-S), and sex-hormone-binding globulin (SHBG) were measured on cycle day 2, 3, or 4, and urinary equol measured on day 7 after a 4-day soy challenge. Subjects then received either probiotic capsules (containing Lactobacillus acidophilus and Bifidobacterium longum) or placebo capsules through day 7 of menstrual cycle 3, at which time both the plasma hormone concentrations and the post-soy challenge urinary equol measurements were repeated.
RESULTS: During menstrual cycle 1, equol excretors and non-excretors were not significantly different with respect to subject characteristics, diet, or hormone concentrations. Significant inverse correlations were found between E(2) and body mass index (BMI) (P=0.02), SHBG and BMI (P=0.01), DHEA-S and dietary fiber (P=0.04), and A and protein:carbohydrate ratio (P=0.02). Probiotic consumption failed to significantly alter equol excretor status or hormone concentrations during menstrual cycle 3, although there were trends towards decreased concentrations of T (P=0.14) and SHBG (P=0.10) in the probiotic group.
CONCLUSIONS: We were unable to verify a previously reported finding of premenopausal equol excretors having plasma hormone concentrations different from those of nonexcretors. Furthermore, a 2-month intervention with probiotic capsules did not significantly alter equol excretion or plasma hormone concentrations.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15213709     DOI: 10.1038/sj.ejcn.1602020

Source DB:  PubMed          Journal:  Eur J Clin Nutr        ISSN: 0954-3007            Impact factor:   4.016


  12 in total

Review 1.  Equol: history, chemistry, and formation.

Authors:  Kenneth D R Setchell; Carlo Clerici
Journal:  J Nutr       Date:  2010-06-02       Impact factor: 4.798

Review 2.  Does equol production determine soy endocrine effects?

Authors:  Dana Shor; Thozhukat Sathyapalan; Stephen L Atkin; Natalie J Thatcher
Journal:  Eur J Nutr       Date:  2012-02-25       Impact factor: 5.614

3.  Equol production changes over time in pre-menopausal women.

Authors:  Adrian A Franke; Jennifer F Lai; Ian Pagano; Yukiko Morimoto; Gertraud Maskarinec
Journal:  Br J Nutr       Date:  2011-09-16       Impact factor: 3.718

Review 4.  Gastrointestinal microflora, food components and colon cancer prevention.

Authors:  Cindy D Davis; John A Milner
Journal:  J Nutr Biochem       Date:  2009-08-27       Impact factor: 6.048

5.  The pharmacokinetic behavior of the soy isoflavone metabolite S-(-)equol and its diastereoisomer R-(+)equol in healthy adults determined by using stable-isotope-labeled tracers.

Authors:  Kenneth Dr Setchell; Xueheng Zhao; Pinky Jha; James E Heubi; Nadine M Brown
Journal:  Am J Clin Nutr       Date:  2009-08-26       Impact factor: 7.045

Review 6.  Absorption, distribution, metabolism, and excretion of isoflavonoids after soy intake.

Authors:  Adrian A Franke; Jennifer F Lai; Brunhild M Halm
Journal:  Arch Biochem Biophys       Date:  2014-06-16       Impact factor: 4.013

7.  Dietary factors influence production of the soy isoflavone metabolite s-(-)equol in healthy adults.

Authors:  Kenneth D R Setchell; Nadine M Brown; Suzanne Summer; Eileen C King; James E Heubi; Sidney Cole; Trish Guy; Bevan Hokin
Journal:  J Nutr       Date:  2013-10-02       Impact factor: 4.798

8.  Soy consumption during menopause.

Authors:  S Bolca; M Bracke; H Depypere
Journal:  Facts Views Vis Obgyn       Date:  2012

Review 9.  Effect of S-equol and Soy Isoflavones on Heart and Brain.

Authors:  Akira Sekikawa; Masafumi Ihara; Oscar Lopez; Chikage Kakuta; Brian Lopresti; Aya Higashiyama; Howard Aizenstein; Yue-Fang Chang; Chester Mathis; Yoshihiro Miyamoto; Lewis Kuller; Chendi Cui
Journal:  Curr Cardiol Rev       Date:  2019

Review 10.  Estrogen Sulfotransferase (SULT1E1): Its Molecular Regulation, Polymorphisms, and Clinical Perspectives.

Authors:  MyeongJin Yi; Masahiko Negishi; Su-Jun Lee
Journal:  J Pers Med       Date:  2021-03-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.